GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Tariff Resilience Score

Australian Clinical Labs (ASX:ACL) Tariff Resilience Score : 0/10 (As of Jul. 16, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Tariff Resilience Score?

Australian Clinical Labs has the Tariff Resilience Score of 0, which implies that the company might have .

Australian Clinical Labs has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Australian Clinical Labs might have .


Australian Clinical Labs  (ASX:ACL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Australian Clinical Labs Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Australian Clinical Labs Business Description

Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Australian Clinical Labs is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well established in the states of Western Australia, South Australia, Victoria, and the Northern Territory.

Australian Clinical Labs Headlines

No Headlines